Cancer Research Technology
Log in Register
Menu

LNCaP Enzalutamide resistant (1) cell line

Info

Catalogue Number 154157
Parental Line LNCaP
Host Human
Disease Keywords Human prostate adenocarcinoma
Model Tumour line
Relevance LNCaP cells are androgen-sensitive human prostate adenocarcinoma cells derived from the left supraclavicular lymph node metastasis from a 50-year-old Caucasian male in 1977. The androgen receptor (AR) in LNCaP cells harbours a T877A mutations which enables the anti-androgen flutamide to act as an agonist. This cell line is the most commonly used for prostate cancer research.
The cell line is a clonal population of LNCaP cells grown chronically in 10 µM next-generation anti-androgen enzalutamide.
Production Details LNCaP cells grown chronically in 10 µM next-generation anti-androgen enzalutamide
Conditional No
Research Area Cancer
Recommended Growing Conditions RPMI-1640 + 10% FBS

References

There are 0 reference entries for this reagent.

References: 0 entry

There is no reference for this reagent yet, feel free to use the button below to suggest one.

Add a reference

References: 0 entry

There is no reference for this reagent yet, feel free to use the button below to suggest one.

Add a reference

Inventor Information